Products
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$5/mo
Lower than 73% of peersNiche median $9/mo
Creators
url Shortener
@u2lrlinks· 1 followers
Launched
9mo ago
2026-02-17 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@u2lrlinks
  • Launched on Product HuntLaunch

    Smart Links. Real Data. Instant Growth.

    Feb 17 · 9mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2026-01-13

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
Free
Active URLs: 5 · URLs / Month: 5 · Clicks / Month: 100
Basic
$5/mo
Standard
$12.99/mo
For Growth
$25.99/mo
dedicated
$70.99/mo

Trial: None · Free tier included · 4 paid tiers ($5–$70.99) · Observed 2026-11-07 · Source page

Entry price $5/mo, Lower than 73% of peers; “Link Shorteners & QR Codes” median is $9/mo.View pricing benchmark

Website snapshots

Indexed 2026-02-17

Key pages

Desktop & mobile archive
Home
u2lr.com/ Snapshot 2026-11-07

Questions & evidence

How much does U2lr Links cost?
Free: Free; Basic: $5/mo; Standard: $12.99/mo; For Growth: $25.99/mo; dedicated: $70.99/mo. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does U2lr Links get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is U2lr Links and what platforms does it support?
U2lr Links is catalogued under Link Shorteners & QR Codes: Short Links, Smarter Analytics. Supported platforms: API.

Related products in this category

Utilities / Link Shorteners & QR Codes

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.